BHG Stock Price, News & Analysis

Bright Health Group (NYSE: BHG) has announced it will report its First Quarter financial results on May 9, 2023, before the markets open, followed by a conference call at 8:00 AM Eastern Time. The company focuses on providing value-driven healthcare to aging and underserved consumers through its Fully Aligned Care Model in major markets including Florida, Texas, and California.

Participants can join the call by pre-registering via a provided link, and a webcast will also be available on the company’s Investor Relations page. Bright Health Group is dedicated to making healthcare accessible and affordable, aiming to address the needs of 26% of the aging U.S. population.

Bright Health Group, Inc. (BHG) reported Q4 2022 revenue of $551.4 million, with a net loss of $188.2 million. For the full year 2022, revenue totaled $2.4 billion, with a net loss of $638 million. The company aims for adjusted EBITDA profitability in 2023, despite lowering revenue expectations due to finalized accounting for value-based care contracts. Bright Health reported over $150 million in cash as of February 24, 2023, but breached liquidity covenants, requiring amendments to its credit agreements. Key metrics show growth in commercial and Medicare Advantage consumers, indicating a focus on value-driven care.

Bright Health Group, Inc. (NYSE: BHG) will report its Fourth Quarter financial results on March 1, 2023, before market opening. A conference call is scheduled for 8:00 AM Eastern Time on the same day, with pre-registration available for telephone participants. The company focuses on providing technology-enabled, value-driven healthcare for aging and underserved consumers through its Fully Aligned Care Model, primarily in Florida, Texas, and California, which together represent a significant portion of the U.S. aging population. Investors can access the earnings call via Bright Health's Investor Relations page.

Bright Health Group (NYSE: BHG) has increased its 2023 enterprise revenue guidance to $3.4 - $3.6 billion, anticipating over 30% year-over-year revenue growth, excluding ACA Marketplace Insurance. The company has reported strong Medicare Advantage enrollment in California, reaffirming its target of over 125K consumers by year-end. Bright Health also emphasized its commitment to Adjusted EBITDA profitability for 2023, supported by a strengthened capital position. CEO Mike Mikan will discuss the outlook further at the J.P. Morgan Healthcare Conference on January 11.

Bright Health Group (NYSE: BHG) announced that CEO Mike Mikan will present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, starting at 6:00 p.m. ET in San Francisco, CA. The event will be available via live webcast, with a replay accessible on Bright Health’s Investor Relations page afterwards. Bright Health is dedicated to serving aging and underserved consumers, focusing on unmet clinical needs through a technology-enabled, value-based healthcare model in key markets such as Florida, Texas, and California.

Bright Health Group (NYSE: BHG) received a notice from the NYSE indicating non-compliance with listing standards due to its stock price being below $1.00 over a consecutive 30-day period ending December 2, 2022. The Company has a six-month period to regain compliance, during which its stock will continue to trade. Options include a potential reverse stock split pending stockholder approval. Non-compliance does not affect ongoing operations or SEC reporting requirements, but failure to meet the minimum price may lead to delisting procedures.